REFERENCES
- O'Keeffe ST. Restless legs syndrome. A review. Arch Intern Med. 1996;156:243–8.
- Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med. 2007;120(Suppl 1):S4–12.
- Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, et al. Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1. PLoS Genet. 2011;7(7):e1002171.
- Ohayon MM, et al. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2011;.
- Sikandar R, Khealani BA, Wasay M. Predictors of restless legs syndrome in pregnancy: a hospital based cross sectional survey from Pakistan. Sleep Med. 2009;10(6):676–8.
- Ishaq M, Muhammad JS, Hameed K, Mirza Al. Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients. Mod Rheumatol. 2011;21:375–80.
- Farooqi AZ, Gibson T. Prevalence of major rheumatic disorders in the adult population of northern Pakistan. Br J Rheum. 1998;37:491–5.
- Gudbjömsson B, Broman JE, Hetta J, Hällgren R. Sleep distur-bances in patients with primary Sjögren's syndrome. Br J Rheumatol. 1993;32:1072.
- Hassan N, Pineau CA, Clarke AE, et al. Systemic lupus and risk of restless legs syndrome. J Rheumatol. 2011;38:874.
- Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ. 1996;312:1339.
- Salih AM, Gray RE, Mills KR, Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheu-matoid arthritis. Br J Rheumatol. 1994;33:60.
- Taylor-Gjevre RM, Gjevre JA, Skomro R, Nair B. Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheu-matol. 2009;15:12–5.
- Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69: 1580–8.
- Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–19.
- Gao X, Schwarzschild MA, Wang H, Ascherio A. Obesity and resles legs syndrome in men and women. Neurology. 2009;72: 1255–61.
- Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160:2137–41.
- Winkelman JW. Considering the causes of RLS. Eur J Neurol. 2006;13(Suppl 3):8–14.
- Kunas RC, McRae A, Kesselring J, Villiger PM. Antidopamin-ergic antibodies in a patient with complex autoimmune disorder and rapidly progressing Parkinson's disease. J Allergy Clin Immunol. 1995;96:688–90.
- Ballok DA, Earls AM, Krasnik C, Hoffman SA, Sakic B. Auto-immune-induced damage of midbrain dopaminergic system in lupus-prone mice. J Neuroimmunol. 2004;152:82–97.
- Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the Risk of Restless Legs Syndrome in the General Popula-tion. Arch Intern Med. 2004; 164:196–20.
- Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160(14):2137.
- Homyak M, Trendwalder C, Kohnen R, Scholz H. Efficacy and safety of dopamine agonists in restless legs syndrome. Sleep Med. 2012;.